87 related articles for article (PubMed ID: 9191402)
1. Mutations to the alpha-2 domain of human class II molecules alters the efficiency of peptide loading and antigen presentation.
Lamikanra A; Grüneberg U; Altmann D; Travers P
Biochem Soc Trans; 1997 May; 25(2):357S. PubMed ID: 9191402
[No Abstract] [Full Text] [Related]
2. In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM.
Lightstone L; Hargreaves R; Bobek G; Peterson M; Aichinger G; Lombardi G; Lechler R
Proc Natl Acad Sci U S A; 1997 May; 94(11):5772-7. PubMed ID: 9159149
[TBL] [Abstract][Full Text] [Related]
3. Suppression of allorecognition by use of synthetic peptides.
Colovai AI; Renna-Molajoni E; Cocciolo PL; Tugulea S; Liu Z; Harris PE; Suciu-Foca N; Cortesini R
Transplant Proc; 1996 Dec; 28(6):3029-31. PubMed ID: 8962175
[No Abstract] [Full Text] [Related]
4. Indirect recognition of native HLA alloantigens and B-cell help.
Suciu-Foca N; Liu Z; Harris PE; Reed EF; Cohen DJ; Benstein JA; Benvenisty AI; Mancini D; Michler RE; Rose EA
Transplant Proc; 1995 Feb; 27(1):455-6. PubMed ID: 7533416
[No Abstract] [Full Text] [Related]
5. HLA-DR alpha chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes.
Fu XT; Karr RW
Hum Immunol; 1994 Apr; 39(4):253-60. PubMed ID: 7520896
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of an HLA-DR alpha-specific monoclonal antibody using L-cell transfectants expressing human and mouse class II major histocompatibility dimers.
Palmer D; Kevany M; Mackworth-Young C; Batchelor R; Lombardi G; Lechler R
Immunogenetics; 1991; 33(1):12-7. PubMed ID: 1995473
[TBL] [Abstract][Full Text] [Related]
7. HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains.
Rich T; Lawler SE; Lord JM; Blancheteau VM; Charron DJ; Mooney NA
J Immunol; 1997 Oct; 159(8):3792-8. PubMed ID: 9378966
[TBL] [Abstract][Full Text] [Related]
8. Recognition by class II alloreactive T cells of processed determinants from human serum proteins.
Panina-Bordignon P; Corradin G; Roosnek E; Sette A; Lanzavecchia A
Science; 1991 Jun; 252(5012):1548-50. PubMed ID: 1710827
[TBL] [Abstract][Full Text] [Related]
9. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.
Barber LD; Lechler RI
J Immunol; 1991 Oct; 147(7):2346-53. PubMed ID: 1717556
[TBL] [Abstract][Full Text] [Related]
10. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
[TBL] [Abstract][Full Text] [Related]
11. Oncogene-derived peptides: a new class of tumor rejection antigens?
Gedde-Dahl T; Olsen BH; Thorsby E; Gaudernack G
Transplant Proc; 1993 Feb; 25(1 Pt 2):1385-6. PubMed ID: 8442151
[No Abstract] [Full Text] [Related]
12. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
[TBL] [Abstract][Full Text] [Related]
13. Transfer of polymorphic monoclonal antibody epitopes to the first and second domains of HLA-DR beta-chains by site-directed mutagenesis.
Maurer D; Gorski J
J Immunol; 1991 Jan; 146(2):621-6. PubMed ID: 1702809
[TBL] [Abstract][Full Text] [Related]
14. T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4.
Merkenschlager M; Altmann DM; Ikeda H
J Immunol; 1990 Nov; 145(10):3181-7. PubMed ID: 1699999
[TBL] [Abstract][Full Text] [Related]
15. Isolation of a human T cell line specific for a streptococcal cell surface antigen.
Brookes RH; Rayfield LS; Bergmeier LA; Shepherd PS
FEMS Microbiol Immunol; 1991 Jun; 3(3):177-83. PubMed ID: 1715178
[TBL] [Abstract][Full Text] [Related]
16. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.
Wicker LS; Chen SL; Nepom GT; Elliott JF; Freed DC; Bansal A; Zheng S; Herman A; Lernmark A; Zaller DM; Peterson LB; Rothbard JB; Cummings R; Whiteley PJ
J Clin Invest; 1996 Dec; 98(11):2597-603. PubMed ID: 8958223
[TBL] [Abstract][Full Text] [Related]
17. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma.
Jäger E; Jäger D; Karbach J; Chen YT; Ritter G; Nagata Y; Gnjatic S; Stockert E; Arand M; Old LJ; Knuth A
J Exp Med; 2000 Feb; 191(4):625-30. PubMed ID: 10684854
[TBL] [Abstract][Full Text] [Related]
18. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
Mellins E; Cameron P; Amaya M; Goodman S; Pious D; Smith L; Arp B
J Exp Med; 1994 Feb; 179(2):541-9. PubMed ID: 8294865
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
20. Modulation of promiscuous T cell receptor recognition by mutagenesis of CDR2 residues.
Brawley JV; Concannon P
J Exp Med; 1996 May; 183(5):2043-51. PubMed ID: 8642315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
